Wolfgang-michael M. Franz

Innsbruck, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Impact of a telemonitoring intervention in patients with chronic heart failure in Germany: A difference-in-difference matching approach using real-world data.

Impact of a telemonitoring intervention in patients with chronic heart failure in Germany: A difference-in-difference matching approach using real-world data.

Journal: Journal of telemedicine and telecare

Published: February 09, 2021

Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.

Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: October 19, 2016

Diagnostic and prognostic value of miR-1 and miR-29b on adverse ventricular remodeling after acute myocardial infarction - The SITAGRAMI-miR analysis.

Diagnostic and prognostic value of miR-1 and miR-29b on adverse ventricular remodeling after acute myocardial infarction - The SITAGRAMI-miR analysis.

Journal: International journal of cardiology

Published: September 18, 2016

Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trial.

Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trial.

Journal: International journal of cardiology

Published: February 21, 2016

Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).

Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).

Journal: International journal of cardiology

Published: October 27, 2015

Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease.

Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: September 04, 2015

Generation of cardiac pacemaker cells by programming and differentiation.

Generation of cardiac pacemaker cells by programming and differentiation.

Journal: Biochimica et biophysica acta

Published: August 31, 2015

High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.

High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.

Journal: International journal of cardiology

Published: August 27, 2015

Pharmacological DPP4 inhibition for the prevention of vascular diseases.

Pharmacological DPP4 inhibition for the prevention of vascular diseases.

Journal: International journal of cardiology

Published: August 11, 2015

Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study.

Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study.

Journal: Wiener klinische Wochenschrift

Published: July 24, 2015

Aortic stiffness is associated with elevated high-sensitivity cardiac troponin T concentrations at a chronic stage after ST-segment elevation myocardial infarction.

Aortic stiffness is associated with elevated high-sensitivity cardiac troponin T concentrations at a chronic stage after ST-segment elevation myocardial infarction.

Journal: Journal of hypertension

Published: July 07, 2015

FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.

FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.

Journal: European heart journal. Cardiovascular Imaging

Published: May 28, 2015

Showing 1-12 of 40

Last Updated: 09/26/2026